PXD101 in Treating Patients With Myelodysplastic Syndromes
by on Tuesday, August 14th, 2012 | No Comments
Condition: Myelodysplastic Syndromes
Intervention: Drug: belinostat
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Completed – verified July 2009
The rest is here: PXD101 in Treating Patients With Myelodysplastic Syndromes